Elanco Animal Health Incorporat - stock earnings

ELAN Quarterly earnings

DateEarningsRevenue
2023Q4 -141.0 million USD 1.0 billion USD
2023Q3 -1.1 billion USD 1.1 billion USD
2023Q2 -97.0 million USD 1.1 billion USD
2023Q1 103.0 million USD 1.3 billion USD
2022Q4 -54.0 million USD 988.0 million USD
2022Q3 -49.0 million USD 1.0 billion USD
2022Q2 -22.0 million USD 1.2 billion USD
2022Q1 51.0 million USD 1.2 billion USD
2021Q4 -97.0 million USD 1.1 billion USD
2021Q3 -104.0 million USD 1.1 billion USD
2021Q2 -210.0 million USD 1.3 billion USD
2021Q1 -61.0 million USD 1.2 billion USD
2020Q4 -322.8 million USD 1.1 billion USD
2020Q3 -135.0 million USD 889.6 million USD
2020Q2 -53.2 million USD 586.3 million USD
2020Q1 -49.1 million USD 657.7 million USD
2019Q4 -9.5 million USD 787.0 million USD
2019Q3 10.0 million USD 771.3 million USD
2019Q2 35.9 million USD 781.6 million USD
2019Q1 31.5 million USD 731.1 million USD
2018Q4 16.4 million USD 799.3 million USD
2018Q3 60.2 million USD 761.1 million USD
2018Q2 -62.8 million USD 770.2 million USD
2018Q1 72.7 million USD 736.2 million USD
2017Q4 -161.5 million USD 754.3 million USD
2017Q3 -20.7 million USD 697.1 million USD
2017Q2 -64.3 million USD 718.8 million USD
2017Q1 -64.3 million USD 718.8 million USD
2016Q4 -47.9 million USD 2.9 billion USD

ELAN Yearly earnings

DateEarningsRevenue
2023 -1.2 billion USD 4.4 billion USD
2022 -74.0 million USD 4.4 billion USD
2021 -472.0 million USD 4.8 billion USD
2020 -560.1 million USD 3.3 billion USD
2019 67.9 million USD 3.1 billion USD
2018 86.5 million USD 3.1 billion USD
2017 -310.7 million USD 2.9 billion USD
2016 -47.9 million USD 2.9 billion USD
2015 -210.8 million USD 2.9 billion USD

ELAN

Price: $13.53

52 week price:
7.88
16.88

Earnings Per Share: -2.50 USD

P/E Ratio: -6.90

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 5.1 million

Market Capitalization: 7.7 billion

Links: